DOSPA HCl | 282533-23-7 | Cationic lipid | CAS#unknown

MedKoo Cat#: 465250 | Name: DOSPA HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DOSPA is a cationic lipid for RNA and vaccine delivery.

Chemical Structure

DOSPA HCl

CAS#282533-23-7 (chlroide 4HCl)

Theoretical Analysis

MedKoo Cat#: 465250

Name: DOSPA HCl

CAS#: 282533-23-7 (chlroide 4HCl)

Chemical Formula: C54H115Cl5N6O3

Exact Mass: 0.0000

Molecular Weight: 1073.80

Elemental Analysis: C, 60.40; H, 10.80; Cl, 16.51; N, 7.83; O, 4.47

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

682737-28-6 (cation) 913238-93-4 (S-isomer cation) 913238-93-4 (Chloride HCl) 282533-23-7 (chlroide 4HCl) 156180-29-9 (bromide) 156180-29-9 (chloride) 913194-16-8 (S-isomer Chloride 4HCl)

Synonym

DOSPA; DOSPA HCl; DOSPA hydrochloride;

IUPAC/Chemical Name

N-(2-(2,5-bis((3-aminopropyl)amino)pentanamido)ethyl)-N,N-dimethyl-2,3-bis(((Z)-octadec-9-en-1-yl)oxy)propan-1-aminium chloride tetrahydrochloride

InChi Key

RYQDMINLUXGGGS-AYXXFMLISA-N

InChi Code

InChI=1S/C54H110N6O3.5ClH/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-48-62-51-52(63-49-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2)50-60(3,4)47-46-59-54(61)53(58-45-39-42-56)40-37-43-57-44-38-41-55;;;;;/h19-22,52-53,57-58H,5-18,23-51,55-56H2,1-4H3;5*1H/b21-19-,22-20-;;;;;

SMILES Code

NCCCNCCCC(NCCCN)C(NCC[N+](C)(CC(COCCCCCCCC/C=C\CCCCCCCC)OCCCCCCCC/C=C\CCCCCCCC)C)=O.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[Cl-]

Appearance

Liquid

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,073.80 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Moon IJ, Kang H, Seu YB, Chang BC, Song DK, Park JG. Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex. Int J Mol Med. 2007 Oct;20(4):429-37. PMID: 17786272. 2: Hirsch-Lerner D, Zhang M, Eliyahu H, Ferrari ME, Wheeler CJ, Barenholz Y. Effect of "helper lipid" on lipoplex electrostatics. Biochim Biophys Acta. 2005 Aug 15;1714(2):71-84. doi: 10.1016/j.bbamem.2005.04.008. PMID: 16051183. 3: Boulanger C, Di Giorgio C, Gaucheron J, Vierling P. Transfection with fluorinated lipoplexes based on new fluorinated cationic lipids and in the presence of a bile salt surfactant. Bioconjug Chem. 2004 Jul-Aug;15(4):901-8. doi: 10.1021/bc049942+. PMID: 15264880. 4: Lee Y, Koo H, Lim YB, Lee Y, Mo H, Park JS. New cationic lipids for gene transfer with high efficiency and low toxicity: T-shape cholesterol ester derivatives. Bioorg Med Chem Lett. 2004 May 17;14(10):2637-41. doi: 10.1016/j.bmcl.2004.02.061. PMID: 15109668. 5: Ota T, Maeda M, Tatsuka M. Cationic liposomes with plasmid DNA influence cancer metastatic capability. Anticancer Res. 2002 Nov-Dec;22(6C):4049-52. PMID: 12553031. 6: Hong YS, Laks H, Cui G, Chong T, Sen L. Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. J Heart Lung Transplant. 2002 Nov;21(11):1188-200. doi: 10.1016/s1053-2498(02)00417-5. PMID: 12431492. 7: Simberg D, Danino D, Talmon Y, Minsky A, Ferrari ME, Wheeler CJ, Barenholz Y. Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J Biol Chem. 2001 Dec 14;276(50):47453-9. doi: 10.1074/jbc.M105588200. Epub 2001 Sep 19. PMID: 11564736. 8: Toyoda K, Nakane H, Heistad DD. Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo. J Cereb Blood Flow Metab. 2001 Sep;21(9):1125-31. doi: 10.1097/00004647-200109000-00010. PMID: 11524617. 9: Baccaglini L, Shamsul Hoque AT, Wellner RB, Goldsmith CM, Redman RS, Sankar V, Kingman A, Barnhart KM, Wheeler CJ, Baum BJ. Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo. J Gene Med. 2001 Jan-Feb;3(1):82-90. doi: 10.1002/1521-2254(2000)9999:9999<::AID- JGM151>3.0.CO;2-X. PMID: 11269339. 10: Even-Chen S, Barenholz Y. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids. Biochim Biophys Acta. 2000 Dec 20;1509(1-2):176-88. doi: 10.1016/s0005-2736(00)00292-3. PMID: 11118529. 11: Koch S, Pohl P, Cobet U, Rainov NG. Ultrasound enhancement of liposome- mediated cell transfection is caused by cavitation effects. Ultrasound Med Biol. 2000 Jun;26(5):897-903. doi: 10.1016/s0301-5629(00)00200-3. PMID: 10942837. 12: Winklhofer KF, Tatzelt J. Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells. Biol Chem. 2000 May- Jun;381(5-6):463-9. doi: 10.1515/BC.2000.061. PMID: 10937879. 13: Islam A, Handley SL, Thompson KS, Akhtar S. Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems. J Drug Target. 2000;7(5):373-82. doi: 10.3109/10611869909085520. PMID: 10721799. 14: Kisich KO, Malone RW, Feldstein PA, Erickson KL. Specific inhibition of macrophage TNF-alpha expression by in vivo ribozyme treatment. J Immunol. 1999 Aug 15;163(4):2008-16. PMID: 10438938. 15: Yu W, Shimoyama A, Uneda T, Obika S, Miyashita K, Doi T, Imanishi T. Gene transfer mediated by YKS-220 cationic particles: convenient and efficient gene delivery reagent. J Biochem. 1999 Jun;125(6):1034-8. doi: 10.1093/oxfordjournals.jbchem.a022383. PMID: 10348904. 16: David SA, Silverstein R, Amura CR, Kielian T, Morrison DC. Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother. 1999 Apr;43(4):912-9. doi: 10.1128/AAC.43.4.912. PMID: 10103199; PMCID: PMC89225. 17: Obika S, Yu W, Shimoyama A, Uneda T, Minami T, Miyashita K, Doi T, Imanishi T. Properties of cationic liposomes composed of cationic lipid YKS-220 having an ester linkage: adequate stability, high transfection efficiency, and low cytotoxicity. Biol Pharm Bull. 1999 Feb;22(2):187-90. doi: 10.1248/bpb.22.187. PMID: 10077439. 18: Swaney WP, Sorgi FL, Bahnson AB, Barranger JA. The effect of cationic liposome pretreatment and centrifugation on retrovirus-mediated gene transfer. Gene Ther. 1997 Dec;4(12):1379-86. doi: 10.1038/sj.gt.3300529. PMID: 9472562. 19: Dybing J, Lynch CM, Hara P, Jurus L, Kiem HP, Anklesaria P. GaLV pseudotyped vectors and cationic lipids transduce human CD34+ cells. Hum Gene Ther. 1997 Sep 20;8(14):1685-94. doi: 10.1089/hum.1997.8.14-1685. PMID: 9322871. 20: Budker V, Hagstrom JE, Lapina O, Eifrig D, Fritz J, Wolff JA. Protein/amphipathic polyamine complexes enable highly efficient transfection with minimal toxicity. Biotechniques. 1997 Jul;23(1):139, 142-7. doi: 10.2144/97231rr02. PMID: 9232246.